ADVANCING ORPHAN ONCOLOGY

TO IMPROVE THE LIFE OF PEOPLE LIVING WITH CANCER BY OFFERING BETTER TREATMENT OPTIONS

OUR STORY

Our Vision

Our vision is to be a leader in identifying, developing and commercializing novel drugs that address unmet needs of people with rare cancer conditions.

 

Learn more about us:

Ascelia Pharma company presentation Oct 2021

Q3-2021 investor conference call

EXHIBITION

Meet us at RSNA in Chicago

November 28 – December 2

Ascelia Pharma will be at the world’s largest radiology conference RSNA in Chicago.

On 1st December, Dr. Kohkan Shamsi will present the abstract for Orviglance comparison study to gadolinium.